Reported Consolidated quarterly numbers for Titan Bio-Tech are:Net Sales at Rs 39.42 crore in June 2020 up 78.42% from Rs. 22.09 crore in June 2019.
Quarterly Net Profit at Rs. 12.74 crore in June 2020 up 551.27% from Rs. 1.96 crore in June 2019.
EBITDA stands at Rs. 18.41 crore in June 2020 up 296.77% from Rs. 4.64 crore in June 2019.
Titan Bio-Tech EPS has increased to Rs. 15.42 in June 2020 from Rs. 2.37 in June 2019.
Titan Bio-Tech shares closed at 94.10 on August 06, 2020 (BSE) and has given 133.79% returns over the last 6 months and 165.07% over the last 12 months.
| Titan Bio-Tech | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'20 | Mar'20 | Jun'19 | | Net Sales/Income from operations | 39.42 | 20.08 | 22.09 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 39.42 | 20.08 | 22.09 | | EXPENDITURE | | Consumption of Raw Materials | 14.81 | 9.54 | 11.70 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.67 | -0.38 | 0.11 | | Power & Fuel | -- | -- | -- | | Employees Cost | 2.94 | 3.49 | 2.78 | | Depreciation | 0.45 | 0.45 | 0.44 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.16 | 4.27 | 2.98 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 17.72 | 2.72 | 4.09 | | Other Income | 0.23 | 0.18 | 0.11 | | P/L Before Int., Excpt. Items & Tax | 17.96 | 2.90 | 4.20 | | Interest | 0.37 | 0.61 | 0.60 | | P/L Before Exceptional Items & Tax | 17.58 | 2.29 | 3.60 | | Exceptional Items | 0.09 | -- | -- | | P/L Before Tax | 17.67 | 2.29 | 3.60 | | Tax | 4.45 | 0.34 | 1.00 | | P/L After Tax from Ordinary Activities | 13.22 | 1.95 | 2.60 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 13.22 | 1.95 | 2.60 | | Minority Interest | -0.48 | -0.02 | -0.64 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 12.74 | 1.92 | 1.96 | | Equity Share Capital | 8.26 | 8.26 | 8.26 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 15.42 | 2.33 | 2.37 | | Diluted EPS | 15.42 | 2.33 | 2.37 | | EPS After Extra Ordinary | | Basic EPS | 15.42 | 2.33 | 2.37 | | Diluted EPS | 15.42 | 2.33 | 2.37 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
First Published on Aug 7, 2020 09:08 am
